Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRTM2 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
mRNA | WNK3 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
mRNA | AK8 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
mRNA | ARHGAP31 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
mRNA | USO1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
mRNA | PLXNB1 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
mRNA | RUNX3 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.05 |
mRNA | MORC4 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
mRNA | FMNL3 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
mRNA | ATP6V0A1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |